This article may include affiliate links
Patents behind Ozempic, and other weight-loss drugs Behind Novo Nordisks weight-loss drugs, such as Ozempic and Wegovy, is a growing portfolio of patents covering semaglutide formulations, delivery methods, and dosing strategies
Personalized Health Plans : At Pileggi, we tailor each program to fit your unique needs
Some of my patients minimize the side effects of GLP-1 medication because they dont want to lower their dose or stop taking it, which can lead to serious complications
Oral semaglutide does not affect the bioavailability of the combined oral contraceptive ethinylestradiol/levonorgestrel
It may need to be discontinued if tolerance develops, as increasing the dose may be linked to serious health risks